SH, H., E, B., & M, N. (2019). Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study. Thrombosis and haemostasis, 119(6), 882. https://doi.org/10.1055/s-0039-1683428
Chicago Style (17th ed.) CitationSH, Hohnloser, Basic E, and Nabauer M. "Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study." Thrombosis and Haemostasis 119, no. 6 (2019): 882. https://doi.org/10.1055/s-0039-1683428.
MLA (9th ed.) CitationSH, Hohnloser, et al. "Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study." Thrombosis and Haemostasis, vol. 119, no. 6, 2019, p. 882, https://doi.org/10.1055/s-0039-1683428.